A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM)
Clinical trial NCT04502446 · TERMINATED
Trial details
- NCT number
- NCT04502446
- Sponsor
- CRISPR Therapeutics AG
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-31
- Primary completion
- 2024-08-30
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.